Sepideh Vahid Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2019	Neural Transcription Factors in Disease Progression.
11/2018	Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer.
1/2017	The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
3/2015	Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sepideh Vahid Research Topics

Disease

4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 03/2015
4	Neoplasms (Cancer) 01/2017 - 03/2015
2	Adenocarcinoma 01/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2015
1	Disease Progression 01/2019
1	Chronic Renal Insufficiency 09/2012
1	Hemorrhage 09/2012

Drug/Important Bio-Agent (IBA)

3	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 01/2017
3	Molecular Chaperones (Chaperone, Molecular)IBA 01/2017 - 03/2015
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2017
2	AndrogensIBA 01/2019 - 11/2018
1	Cell Cycle ProteinsIBA 01/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	PlasticsIBA 01/2019
1	enzalutamideIBA 11/2018
1	galiellalactoneIBA 11/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	HSP27 Heat-Shock ProteinsIBA 01/2016
1	CateninsIBA 03/2015
1	Epidermal Growth Factor (EGF)IBA 03/2015
1	NitratesIBA 09/2012
1	NitritesIBA 09/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2012

Therapy/Procedure

4	Castration 01/2019 - 03/2015
3	Therapeutics 01/2019 - 01/2017